Edesa Biotech, Inc.

NasdaqCM:EDSA Stock Report

Market Cap: US$6.3m

Edesa Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:EDSA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Mar 24BuyUS$20,000Pardeep NijhawanIndividual5,000US$4.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EDSA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies150,9554.35%
Institutions161,3484.65%
Individual Insiders587,19216.9%
General Public2,568,16374.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.6%.

Top Shareholders

Top 25 shareholders own 25.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Pardeep Nijhawan
485,370US$878.5k13.8%no data
3.17%
CM Management, LLC
110,000US$199.1k22.2%0.16%
1.91%
Thomas Satterfield
66,348US$120.1k0%no data
1.53%
1968160 Ontario Inc.
53,104US$96.1k0%no data
0.94%
The New Nijhawan Family Trust 2015
32,609US$59.0k0%no data
0.92%
The Digestive Health Clinic Inc.
32,013US$57.9k0%no data
0.63%
A.G Family LP
21,696US$39.3k0%no data
0.6%
Geode Capital Management, LLC
20,809US$37.7k14.2%no data
0.46%
The Vanguard Group, Inc.
15,864US$28.7k0%no data
0.34%
Frank Oakes
11,669US$21.1k0%no data
0.33%
York-Cav Enterprises, Inc.
11,533US$20.9k0%no data
0.33%
Dimensional Fund Advisors LP
11,333US$20.5k0%no data
0.23%
Rebecca Satterfield
8,000US$14.5k0%no data
0.17%
Stephen Lemieux
5,764US$10.4k0%no data
0.13%
Michael Brooks
4,354US$7.9k0%no data
0.075%
Charles Olson
2,618US$4.7k0%no data
0.059%
Sean MacDonald
2,053US$3.7k0%no data
0.05%
RBC Dominion Securities Inc., Asset Management Arm
1,737US$3.1k0%no data
0.029%
Tower Research Capital Europe Limited
1,016US$1.8k-58.5%no data
0.015%
Carlo Sistilli
522US$944.60%no data
0.013%
Patrick Marshall
465US$841.70%no data
0.007%
Avion Wealth, LLC
242US$438.10%no data
0.0041%
Toronto-Dominion Bank, Banking Investments
142US$256.70%no data
0.0029%
ClearArc Capital, Inc.
100US$180.80%no data
0.00084%
Joan Chypyha
29US$52.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 15:53
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Edesa Biotech, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vernon BernardinoH.C. Wainwright & Co.
David BautzZacks Small-Cap Research